Terms: = Sarcomas AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
86 results:
1. Inhibition of the RAF/MEK/erk Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives.
Adamopoulos C; Cave DD; Papavassiliou AG
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338909
[TBL] [Abstract] [Full Text] [Related]
2. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and Cancer Stemness through erk/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract] [Full Text] [Related]
3. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract] [Full Text] [Related]
4. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
5. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/erk signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract] [Full Text] [Related]
6. Hyalinising clear cell carcinoma of the lung: A case report and review of literature.
Chen L; Zhou N; Hu S; Wang F; Xu T; Li T; Fu Y; Luo Y; Chen Y
Medicine (Baltimore); 2023 Jun; 102(25):e34101. PubMed ID: 37352028
[TBL] [Abstract] [Full Text] [Related]
7. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract] [Full Text] [Related]
8. EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization.
Baber A; Legendre P; Palmic P; Lupo-Mansuet A; Burroni B; Azoulay C; Szwebel TA; Costedoat-Chalumeau N; Leroy K; Blons H; Blay JY; Boudou-Rouquette P; Terrier B
Int J Surg Pathol; 2024 Feb; 32(1):150-154. PubMed ID: 37157817
[TBL] [Abstract] [Full Text] [Related]
9. Adamantinoma-Like Ewing Sarcoma Mimicking Merkel Cell Carcinoma in the Parotid Gland: A Diagnostic Pitfall.
Saikia K; Alruwaii FI; Wu V; Keller C; Chitale D; Al-Obaidy KI
Int J Surg Pathol; 2024 Feb; 32(1):115-118. PubMed ID: 37128815
[TBL] [Abstract] [Full Text] [Related]
10. FKBP11 improves the malignant property of osteosarcoma cells and acts as a prognostic factor of osteosarcoma.
Zeng D; Li J; Yuan X; Cai F; Yu B; Liu L; Chen Q; Zhang F; Liang Y; Tang X; Peng Y; Qu G; Wu P; Jiao Q; Sun L; Lv XB; Liao Q
Aging (Albany NY); 2023 Apr; 15(7):2450-2459. PubMed ID: 37014329
[TBL] [Abstract] [Full Text] [Related]
11. prognosis-related VDAC1 regulates the proliferation and apoptosis of osteosarcoma cells via the MAPK signaling pathway.
Cai X; Zhu S
Genomics; 2023 May; 115(3):110595. PubMed ID: 36871636
[TBL] [Abstract] [Full Text] [Related]
12. Ursonic acid inhibits migration and invasion of human osteosarcoma cells through the suppression of mitogen-activated protein kinases and matrix metalloproteinases.
Son J; Cha H; Lee S; Bae Y; Ryou C; Lee SY
Mol Biol Rep; 2023 May; 50(5):4029-4038. PubMed ID: 36848005
[TBL] [Abstract] [Full Text] [Related]
13. Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition.
Li X; Wang F; Zhang X; Sun Q; Kuang E
PLoS Pathog; 2023 Jan; 19(1):e1011103. PubMed ID: 36656913
[TBL] [Abstract] [Full Text] [Related]
14. Dioscin induces osteosarcoma cell apoptosis by upregulating ROS-mediated p38 MAPK signaling.
Zheng GZ; Zhang QH; Chang B; Xie P; Liao H; Du SX; Li XD
Drug Dev Res; 2023 Feb; 84(1):25-35. PubMed ID: 36401839
[TBL] [Abstract] [Full Text] [Related]
15. Sorafenib inhibits doxorubicin-induced PD-L1 upregulation to improve immunosuppressive microenvironment in Osteosarcoma.
Wang J; Hu F; Yu P; Wang J; Liu Z; Bao Q; Zhang W; Wen J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5127-5138. PubMed ID: 36348018
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical expressions of EMT markers in pan-RAS-perk1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Tripathi K; Maurya N; Goel A; Singhai A; Garg M
Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
[TBL] [Abstract] [Full Text] [Related]
17. Pseudoangiosarcomatous squamous cell carcinoma: a rare subtype of squamous cell carcinoma that needs to be differentiated from angiosarcoma and has a poor prognosis.
Zhan Y; Wan H; Wu L; Ge X; Xie X; Wu L; Cai Y
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):62-66. PubMed ID: 36227677
[TBL] [Abstract] [Full Text] [Related]
18. Metastatic malignant peripheral nerve sheath tumour in a patient with neurofibromatosis 1 and review of contemporary systemic treatments.
Hones K; Krekora U; Nasri E; Altshuler E
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36192032
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR.
Kao EY; Wakeman KM; Wu Y; Gross JM; Chen EY; Ricciotti RW; Liu YJ; Mantilla JG
Hum Pathol; 2022 Nov; 129():90-97. PubMed ID: 36067829
[TBL] [Abstract] [Full Text] [Related]
20. Magnolol Suppresses erk/NF-κB Signaling and Triggers Apoptosis Through Extrinsic/Intrinsic Pathways in Osteosarcoma.
Li CH; Ku MC; Lee KC; Yueh PF; Hsu FT; Lin RF; Yang CC; Wang WC; Chen JH; Hsu LC; Lee YH
Anticancer Res; 2022 Sep; 42(9):4403-4410. PubMed ID: 36039427
[TBL] [Abstract] [Full Text] [Related]
[Next]
